metformin vs glp 1 weight loss GLP-1 Medications for Loss: Semaglutide Tirzepatide vs Retat – Revolution Health & Wellness Metformin vs. Ozempic: Key Differences

Noom Med pairs psychology tools with telehealth prescribing

Here are the key recommendations: 1 Type 2 Diabetes with No Relevant Comorbidities First-line therapy: Modified-release Metformin + SGLT2 inhibitor If Metformin is contraindicated or not tolerated: SGLT2 inhibitor monotherapy 2 Type 2 Diabetes with Heart Failure Initial therapy: Modified-release Metformin + SGLT2 inhibitor If Metformin cannot be used: SGLT2 inhibitor alone 3 Type 2 Diabetes with Atherosclerotic Cardiovascular Disease (ASCVD) Recommended combination therapy: Metformin SGLT2 inhibitor Semaglutide (up to 1 mg weekly) If Metformin is contraindicated: SGLT2 inhibitor + Semaglutide 4 Early-Onset Type 2 Diabetes Initial treatment: Modified-release Metformin + SGLT2 inhibitor Consider adding: GLP-1 receptor agonist or Tirzepatide for improved glycemic and cardiometabolic outcomes 5 Type 2 Diabetes with Obesity Recommended first-line therapy: Modified-release Metformin + SGLT2 inhibitor Additional weight-focused therapies may be considered based on individual patient needs

Noelani Rodriguez is here to answer your questions and get you started

Study links e-cigarette use with higher risk of heart Large study adds to growing body of evidence that vaping may harm the heart [press release]

In large randomized trials, semaglutide 2.4 mg the active ingredient used in medicines like Ozempic produced about 15 percent average weight loss over 68 weeks when paired with basic lifestyle support

Gastroenterology, 132(6), 2131-2157